Biomedical engineers at Johns Hopkins University have achieved a groundbreaking milestone in organoid research by creating multi-region brain organoids (MRBOs). These MRBOs contain interconnected, functional tissues from various regions of the human brain, offering a closer resemblance to a natural human brain than traditional animal models.
With 6–7 million neurons in each MRBO, these organoids provide a unique opportunity for in-depth analysis, particularly in the realm of experimental drug trials. By utilizing MRBOs in drug development, researchers aim to address the high failure rates of medications, especially in the field of neuropsychiatric drugs. This innovative approach could significantly enhance the success and efficiency of drug development processes. The potential applications of whole-brain organoids extend beyond drug trials, opening doors to new avenues of neurophysiological research, personalized medicine, and artificial intelligence development.
Read more from yahoo.com